The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.
Hepatology. 2008 Mar;47(3):817-26. doi: 10.1002/hep.22131.
Hepatology. 2008.
PMID: 18302285
Clinical Trial.